Loading clinical trials...

Kinesiophobia and Physical Fitness, and Related Factors in Liver Transplantation | Clinical Trials | Clareo Health

COMPLETED

Kinesiophobia and Physical Fitness, and Related Factors in Liver Transplantation

An Evaluation of Balance, Functional Capacity, Kinesiophobia and Physical Fitness in Patients With Liver Transplantation

NCT04031924•Hacettepe University

View on ClinicalTrials.gov

Summary

Eligibility

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•All patients older than 18 years of age who had undergone liver transplantation at Hacettepe University Hospital at least one year ago were eligible for the study.

Exclusion Criteria

•Hepatic encephalopathy
•Progressive cardiac and/or pulmonary disease
•Central nervous system pathologies
•Orthopedic problems preventing physical assessments
•Multiorgan transplantation
•Cognitive deficits

Locations (1)

Hacettepe University

Ankara, Turkey (Türkiye)

Key Dates

Start Date

December 20, 2017

Primary Completion Date

July 20, 2018

Completion Date

October 20, 2018

Last Updated

July 24, 2019

Enrollment

ACTUAL participants

Conditions

Liver Transplant Disorder

Interventions

Assessment of: 1. Functional Capacity 2. Physical Fitness 3. Physical Activity Level 4. Balance 5. Kinesiophobia 6. Psychological Status 7. Fatigue Severity

OTHER

Viability Assessment Using FMN Measured in Perfusate and Bile During Normothermic Machine Perfusion

NCT07315204

Liver Transplant Disorder

View study

ACTIVE_NOT_RECRUITINGNA

SBRT for Liver Cancer Before Liver Transplantation

NCT04186234

Liver CancerLiver Transplant Disorder

View study

ACTIVE_NOT_RECRUITINGNA

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 24, 2019Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Kinesiophobia and Physical Fitness, and Related Factors in Liver Transplantation

Inclusion Criteria

Exclusion Criteria

Viability Assessment Using FMN Measured in Perfusate and Bile During Normothermic Machine Perfusion

SBRT for Liver Cancer Before Liver Transplantation

The Effect of Teleyoga in Liver Transplant Patients

Intraoperative Carotid Peak Systolic Velocity Variability in Liver Transplant Patients

Alterations in Coagulation Factor Levels in Patients With End Stage Liver Disease

Liver Transplantation With Two-stage Liver Resection in Unresectable Liver Cancer , Metastases or Emd-stage Liver Disease (LTLR-LC)